0001209191-23-057558.txt : 20231205
0001209191-23-057558.hdr.sgml : 20231205
20231205200013
ACCESSION NUMBER: 0001209191-23-057558
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arif Bilal
CENTRAL INDEX KEY: 0001959750
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 231468201
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-01
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001959750
Arif Bilal
215 FIRST STREET
CAMBRIDGE
MA
02129
0
1
0
0
Chief Tech Ops Officer
0
Common Stock
2023-12-01
4
F
0
3682
80.34
D
22886
D
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021.
Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2023.
/s/ Ryan Brown, as Attorney-in-Fact for Bilal Arif
2023-12-05